NewsBenzinga프라임 메디슨, 알파-1 항트립신 결핍증 치료용 생체 내 프라임 에디터 ‘PM647’의 임상시험계획(IND) 신청 FDA 승인 프라임 메디슨, 알파-1 항트립신 결핍증 치료용 생체 내 프라임 에디터 ‘PM647’의 임상시험계획(IND) 신청 FDA 승인 Benzinga 2026.09.24 20:02 (GMT+0) Open on Benzinga Other news Scholastic Reports Q1 2027 Results: Full Earnings Call Transcript Costco Exec Says We Received $184M In IEEPA Tariff Refunds In The Q4; In Q1 Of FY27, We Have Already Received Similar Amount Of Refunds As We Did In Q4 Here's How Much $100 Invested In Amazon.com 10 Years Ago Would Be Worth Today 12 Health Care Stocks Moving In Thursday's After-Market Session 12 Communication Services Stocks Moving In Thursday's After-Market Session 12 Information Technology Stocks Moving In Thursday's After-Market Session
Costco Exec Says We Received $184M In IEEPA Tariff Refunds In The Q4; In Q1 Of FY27, We Have Already Received Similar Amount Of Refunds As We Did In Q4
